Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H17N3O |
Molar mass | 255.321 g·mol |
3D model (JSmol) | |
SMILES
|
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant. It is structurally and pharmacologically related to pirlindole.
See also
References
- Andreeva NI, Golovina SM, Faermark MF, Shvarts GI, Mashkovskiĭ MD (1991). "". Farmakologiia i Toksikologiia (in Russian). 54 (2): 38–40. PMID 1884793.
Anxiolytics (N05B) | |
---|---|
5-HT1ARTooltip 5-HT1A receptor agonists | |
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators |
|
Hypnotics | |
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Antipsychotics | |
Sympatholytics (Antiadrenergics) |
|
Others | |
|
Monoamine metabolism modulators | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Non-specific |
| ||||||||||
Phenethylamines (dopamine, epinephrine, norepinephrine) |
| ||||||||||
Tryptamines (serotonin, melatonin) |
| ||||||||||
Histamine |
| ||||||||||
See also: Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins |
Tryptamines | |
---|---|
Tryptamines |
|
N-Acetyltryptamines |
|
α-Alkyltryptamines |
|
Triptans | |
Cyclized tryptamines |
|
Isotryptamines | |
Related compounds |
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |